drugset / Trial / NCT02680561

A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma

NCT02680561

Phase 1 Completed 20 enrolled Teva Branded Pharmaceutical Products R&D, Inc.
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of the study is to characterize the pharmacokinetic profiles of fluticasone propionate and/or salmeterol when delivered as a single oral inhalation dose of Fp MDPI and FS MDPI.

Timeline

Start
2016-04
Primary completion
2016-06
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified Inhaled
Subject fluticasone propionate/salmeterol Unknown Inhaled

Indications